Epitope-vaccine strategy against HIV-1: today and tomorrow
- 31 December 2003
- journal article
- review article
- Published by Elsevier in Immunobiology
- Vol. 208 (4) , 423-428
- https://doi.org/10.1078/0171-2985-00286
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine designFEBS Letters, 2003
- Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2Vaccine, 2003
- Antigenicity and Predefined Specificities of the Multi-Epitope Vaccine in Candidate Consisting of Neutralizing Epitope and Mutated Epitopes Suggested a New Way against HIV-1 MutationImmunobiology, 2001
- Liposome Mediated Antigen Delivery Leads to Induction of CD8+ T Lymphocyte and Antibody Responses against the V3 Loop Region of HIV gp120Cellular Immunology, 2001
- Epitope-vaccine as a new strategy against HIV-1 mutationImmunology Letters, 2001
- Multiepitope Vaccines Intensively Increased Levels of Antibodies Recognizing Three Neutralizing Epitopes on Human Immunodeficiency Virus-1 Envelope ProteinScandinavian Journal of Immunology, 2000
- Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responsesVaccine, 2000
- Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.Journal of Clinical Investigation, 1998
- HIV Type 1 Coreceptors, Neutralization Serotypes, and Vaccine DevelopmentAIDS Research and Human Retroviruses, 1997
- Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5AIDS, 1996